Vulnerability Description
In the Mira hormone monitor device firmware v1.7.1.47 build 01070147, a remote unauthenticated attacker within BLE range (approximately 10–30 meters) can silently rebind the device to an attacker-controlled account, extract stored hormone measurements in cleartext, cause a denial-of-service via malformed or undocumented command opcodes, and passively track the user via a static random BLE address that never rotates.
CVSS Score
HIGH
Related Weaknesses (CWE)
References
- https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-2
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-223-01
FAQ
What is CVE-2026-66875?
CVE-2026-66875 is a vulnerability with a CVSS score of 8.8 (HIGH). In the Mira hormone monitor device firmware v1.7.1.47 build 01070147, a remote unauthenticated attacker within BLE range (approximately 10–30 meters) can silently rebind the device to an attacker-cont...
How severe is CVE-2026-66875?
CVE-2026-66875 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2026-66875?
Check the references section above for vendor advisories and patch information. Review vendor security bulletins for remediation guidance.